The Asia Pacific Kyphoplasty Market would witness market growth of 6.8% CAGR during the forecast period (2022-2028).
Reduced mobility, acute pain, persistent pain, and pain at various levels are just a few of the several ways that back pain can manifest. As a result, people may discover that they need to rely on over-the-counter and prescription drugs to get relief from pain. Back discomfort can be efficiently reduced with kyphoplasty procedures, which lessens the need for painkillers.
In kyphoplasty, a cavity is made in the vertebral body using a balloon, which is then filled with methyl methacrylate. In patients with painful VCFs, kyphoplasty has been shown to be successful in lowering postoperative pain and enhancing mobility and quality of life. According to some reports, the clinical results persisted for up to 2 years of follow-up. The vertebral height, as well as kyphotic angle, have also been demonstrated to improve and be maintained following kyphoplasty, as determined by the radiographic assessment, for up to 2 years. Additionally, early results from kyphoplasty in uncomfortable VCF patients with osteoporosis and tumors have demonstrated improvement in pain & disability scores with a decrease in analgesic prescription use.
The region exhibits strong trends toward better healthcare access overall as it prepares for COVID-19 recovery and resumes the journey towards healthcare improvement. Countries are resuming their commitment to healthcare transformation rather than simply restoring care delivery and quality to pre-pandemic levels. The increasing emphasis on payer-provider relationships, continuous attention to value, and increased investment in digital health have the potential to improve healthcare delivery for populations throughout the Asia Pacific region and advance health systems.
The China market dominated the Asia Pacific Kyphoplasty Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $66.4 million by 2028. The Japan market is estimated to grow a CAGR of 6.1% during (2022 - 2028). Additionally, The India market would experience a CAGR of 7.5% during (2022 - 2028).
Based on Product Type, the market is segmented into Accessories and Kyphoplasty Systems. Based on Indication, the market is segmented into Osteoporosis and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Kyphoplasty Market is Projected to reach USD 837.1 Million by 2028, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, MicroPort Scientific Corporation, IZI Medical Products, LLC (Landauer, Inc.), Merit Medical Systems, Inc., Jiangsu Changmei Medtech Co. Ltd., G21 S.r.l., Seawon Meditech Co., Ltd., joimax® GmbH and Taeyeon medical Co., Ltd.
By Product Type
By Indication
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
